These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8345720)

  • 61. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
    Bukur J; Rebmann V; Grosse-Wilde H; Luboldt H; Ruebben H; Drexler I; Sutter G; Huber C; Seliger B
    Cancer Res; 2003 Jul; 63(14):4107-11. PubMed ID: 12874014
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Immunohistochemical analysis of CD83, CD8 and CD4 positive cells in renal cell carcinoma].
    Aso T; Ogawa Y; Naoe M; Fukagai T; Yoshida H; Kushima M
    Nihon Hinyokika Gakkai Zasshi; 2004 May; 95(4):645-50. PubMed ID: 15197997
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tumor-specific CD4+ T cells from a patient with renal cell carcinoma recognize diverse shared antigens.
    Mautner J; Jaffee EM; Pardoll DM
    Int J Cancer; 2005 Jul; 115(5):752-9. PubMed ID: 15704175
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
    Möller P; Momburg F; Koretz K; Moldenhauer G; Herfarth C; Otto HF; Hämmerling GJ; Schlag P
    Cancer Res; 1991 Jan; 51(2):729-36. PubMed ID: 1985791
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Major histocompatibility complex class I and class II antigen expression in diffuse large cell and large cell immunoblastic lymphomas. Absence of a correlation between antigen expression and clinical outcome.
    Medeiros LJ; Gelb AB; Wolfson K; Doggett R; McGregor B; Cox RS; Horning SJ; Warnke RA
    Am J Pathol; 1993 Oct; 143(4):1086-97. PubMed ID: 8214004
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL; Smith KD; Lutz CT
    J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Interferon-induced protection of renal cell cancer cell lines to lymphokine-activated killer (LAK) cells and effect of acid treatment on their susceptibility. Its relevance to expression of major histocompatibility complex class I antigens on tumor cells].
    Tomita Y; Kimura M; Nishiyama T; Sato S
    Nihon Hinyokika Gakkai Zasshi; 1991 May; 82(5):762-8. PubMed ID: 1908533
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Peptidome from renal cell carcinoma contains antigens recognized by CD4+ T cells and shared among tumors of different histology.
    Tassi E; Facchinetti V; Seresini S; Borri A; Dell'antonio G; Garavaglia C; Casorati G; Protti MP
    Clin Cancer Res; 2006 Aug; 12(16):4949-57. PubMed ID: 16914584
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Antigen presentation and macrophages].
    Toubert A; Charron D
    Pathol Biol (Paris); 1997 Feb; 45(2):126-30. PubMed ID: 9247034
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In cutaneous T-cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared with uninvolved epidermis.
    Hansen ER; Bang B; Larsen JK; Vejlsgaard GL; Baadsgaard O
    Br J Dermatol; 1994 Dec; 131(6):780-8. PubMed ID: 7531998
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.
    Mellins E; Cameron P; Amaya M; Goodman S; Pious D; Smith L; Arp B
    J Exp Med; 1994 Feb; 179(2):541-9. PubMed ID: 8294865
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments.
    Sanderson F; Kleijmeer MJ; Kelly A; Verwoerd D; Tulp A; Neefjes JJ; Geuze HJ; Trowsdale J
    Science; 1994 Dec; 266(5190):1566-9. PubMed ID: 7985027
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Composition of MHC class II-enriched lipid microdomains is modified during maturation of primary dendritic cells.
    Setterblad N; Roucard C; Bocaccio C; Abastado JP; Charron D; Mooney N
    J Leukoc Biol; 2003 Jul; 74(1):40-8. PubMed ID: 12832441
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines.
    Mulders P; Tso CL; Gitlitz B; Kaboo R; Hinkel A; Frand S; Kiertscher S; Roth MD; deKernion J; Figlin R; Belldegrun A
    Clin Cancer Res; 1999 Feb; 5(2):445-54. PubMed ID: 10037196
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunohistological characteristics of the infiltrating lymphoid cells and expression of HLA class I and II antigens in nasopharyngeal carcinoma.
    Lai FM; Cheng PN; Tsao SY; Lai KN
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(4):347-52. PubMed ID: 1978435
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Analysis of immune response to tumor specific antigen restricted to HLA class II on renal cell carcinoma and its recognition mechanism].
    Nishijima S; Sugaya K; Ogawa Y; Mukouyama H; Shimada K
    Nihon Hinyokika Gakkai Zasshi; 2002 Mar; 93(3):457-62. PubMed ID: 11968801
    [TBL] [Abstract][Full Text] [Related]  

  • 77. HLA-DRB alleles are differentially expressed by tumor cells in breast carcinoma.
    Oldford SA; Robb JD; Watson PH; Drover S
    Int J Cancer; 2004 Nov; 112(3):399-406. PubMed ID: 15382064
    [TBL] [Abstract][Full Text] [Related]  

  • 78. HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2.
    Kooi S; Zhang HZ; Patenia R; Edwards CL; Platsoucas CD; Freedman RS
    Cell Immunol; 1996 Dec; 174(2):116-28. PubMed ID: 8954611
    [TBL] [Abstract][Full Text] [Related]  

  • 79. HLA expression in basal cell carcinomas.
    Garcia-Plata D; Mozos E; Sierra MA; Peña J; Solana R
    Invasion Metastasis; 1991; 11(3):166-73. PubMed ID: 1834604
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunohistochemical studies on the expression of HLA class I antigens in renal cell carcinoma: comparison of primary and metastatic tumor tissue.
    Buszello H; Ackermann R
    Eur Urol; 1994; 25(2):158-63. PubMed ID: 8137858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.